自噬
细胞生物学
细胞外基质
比格里坎
卢米坎
多糖
生物
化学
蛋白多糖
生物化学
细胞凋亡
作者
Liliana Schaefer,Ivan Ðikić
出处
期刊:Matrix Biology
[Elsevier BV]
日期:2021-06-01
卷期号:100-101: 1-8
被引量:26
标识
DOI:10.1016/j.matbio.2021.06.002
摘要
In recent years, extensive research has uncovered crucial regulatory roles for the extracellular matrix (ECM) in regulating autophagy. Autophagy is a ubiquitous and highly conserved catabolic process that allows the selective removal and recycling of cytosolic components via lysosomal or vacuolar degradation. Due to its pivotal role in cellular homeostasis, the impairment of autophagy is involved in the pathophysiology of numerous diseases, comprising infectious diseases, immune and neurodegenerative disorders, renal and hepatic diseases, intervertebral and cartilage disorders, as well as fibrosis and cancer. Several ECM-derived proteoglycans and proteins, including decorin, biglycan, endorepellin, endostatin, collagen VI, and plasminogen kringle 5, have been identified as strong inducers of autophagy. In contrast, laminin α2, perlecan, and lumican exert opposite function by suppressing autophagy. Importantly, by direct interaction with various receptors, which interplay with their co-receptors and adhesion molecules, the ECM is able to direct autophagy in a molecular and cell context-specific manner. Thus, vast pharmacological potential resides in translating this knowledge into the development of ECM-derived therapeutics selectively regulating autophagy.
科研通智能强力驱动
Strongly Powered by AbleSci AI